Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial
Titel:
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial
Auteur:
Blay, Jean-Yves Shen, Lin Kang, Yoon-Koo Rutkowski, Piotr Qin, Shukui Nosov, Dmitry Wan, Desen Trent, Jonathan Srimuninnimit, Vichien Pápai, Zsuzsanna Le Cesne, Axel Novick, Steven Taningco, Lilia Mo, Shuyuan Green, Steven Reichardt, Peter Demetri, George D